 BOCA RATON, Fla., Jan. 24, 2023 GLOBE NEWSWIRE -- First Wave BioPharma, Inc. NASDAQ:FWBI First Wave BioPharma or the Company, a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal GI diseases, announced James Sapirstein, Chairman, President and CEO, will present at the Sequire Biotechnology Conference being held virtually on February 2, 2023. 